Coffee induces breast cancer resistance protein expression in Caco-2 cells

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 10, 2011, Pages 1624-1627

  Isshiki, Marina ^a   Umezawa, Kazuo ^a   Tamura, Hiroomi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Breast cancer resistance protein; Caco 2; Coffee; Nuclear factor B

Indexed keywords

ACETIC ACID ETHYL ESTER; BREAST CANCER RESISTANCE PROTEIN; DEHYDROXYMETHYLEPOXYQUINOMICIN; HEXANE; HOE 33342; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; BINDING SITE; BIOACCUMULATION; BREAST CANCER RESISTANCE GENE; CELL STRAIN CACO 2; CELL TRANSPORT; COFFEE; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVATION; FOOD PROCESSING; GASTROINTESTINAL TRACT; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; ROASTING PROCESS; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ATP-BINDING CASSETTE TRANSPORTERS; BENZAMIDES; BENZIMIDAZOLES; BREAST NEOPLASMS; CACO-2 CELLS; CELL CULTURE TECHNIQUES; COFFEE; CYCLOHEXANONES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FEMALE; GENE EXPRESSION; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; NF-KAPPA B; PLANT EXTRACTS;

EID: 80053528626     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.1624     Document Type: Article

References (25)

1. Inoue M., Tajima K., Hirose K., Hamajima N., Takezaki T., Kuroishi T., Tominaga S., Cancer Causes Control, 9, 209-216 (1998).
2. Giovannucci E., Am. J. Epidemiol., 147, 1043-1052 (1998).
3. Tanaka T., Nishikawa A., Shima H., Sugie S., Shinoda T., Yoshimi N., Iwata H., Mori H., Basic Life Sci., 52, 429-440 (1990).
4. Gershbein L. L., Anticancer Res., 14(3A), 1113-1116 (1994).
5. Turesky R. J., Richoz J., Constable A., Curtis K. D., Dingley K. H., Turteltaub K. W., Chem. Biol. Interact., 145, 251-265 (2003).
6. Cavin C., Holzhäuser D., Constable A., Huggett A. C., Schilter B., Carcinogenesis, 19, 1369-1375 (1998).
7. Cavin C., Holzhaeuser D., Scharf G., Constable A., Huber W. W., Schilter B., Food Chem. Toxicol., 40, 1155-1163 (2002).
8. Okamura S., Suzuki K., Yanase M., Koizumi M., Tamura H. O., Biol. Pharm. Bull., 28, 271-274 (2005).
9. Saruwatari A., Isshiki M., Tamura H., Biol. Pharm. Bull., 31, 2131-2136 (2008).
10. Noguchi K., Katayama K., Mitsuhashi J., Sugimoto Y., Adv. Drug Deliv. Rev., 61, 26-33 (2009).
11. Mao Q., Unadkat J. D., AAPS J., 7, E118-E133 (2005).
12. Jumarie C., Malo C., J. Cell. Physiol., 149, 24-33 (1991).
13. Higuchi R., Fockler C., Dollinger G., Watson R., Biotechnology (N.Y.), 11, 1026-1030 (1993).
14. Scharenberg C. W., Harkey M. A., Torok-Storb B., Blood, 99, 507-512 (2002).
15. Allen J. D., van Loevezijn A., Lakhai J. M., van der Valk M., van Tellingen O., Reid G., Schellens J. H., Koomen G. J., Schinkel A. H., Mol. Cancer Ther., 1, 417-425 (2002).
16. Del Castillo M. D., Ames J. M., Gordon M. H., J. Agric. Food Chem., 50, 3698-3703 (2002).
17. Paur I., Balstad T. R., Blomhoff R., Free Radic. Biol. Med., 48, 1218-1227 (2010).
18. Paur I., Balstad T. R., Kolberg M., Pedersen M. K., Austenaa L. M., Jacobs D. R. Jr., Blomhoff R., Cancer Prev. Res. (Philadelphia), 3, 653-663 (2010).
19. Wang X., Wu X., Wang C., Zhang W., Ouyang Y., Yu Y., He Z., FEBS Lett., 584, 3392-3397 (2010).
20. Ariga A., Namekawa J., Matsumoto N., Inoue J., Umezawa K., J. Biol. Chem., 277, 24625-24630 (2002).
21. Robey R. W., To K. K., Polgar O., Dohse M., Fetsch P., Dean M., Bates S. E., Adv. Drug Deliv. Rev., 61, 3-13 (2009).
22. Galeone C., Turati F., La Vecchia C., Tavani A., Cancer Causes Control, 21, 1949-1959 (2010).
23. Higdon J. V., Frei B., Crit. Rev. Food Sci. Nutr., 46, 101-123 (2006).
24. Singh A., Wu H., Zhang P., Happel C., Ma J., Biswal S., Mol. Cancer Ther., 9, 2365-2376 (2010).
25. Tompkins L. M., Li H., Li L., Lynch C., Xie Y., Nakanishi T., Ross D. D., Wang H., Biochem. Pharmacol., 80, 1754-1761 (2010).